MT2 Tablets

MT2 tablets is a synthetic non-selective agonist of melanocortin receptors (MCRs). It specifically binds to various melanocortin receptor subtypes in the body and regulates multiple physiological processes by initiating downstream signaling pathways. Recent studies have gradually extended its research scope to the fields of anti-inflammatory, immunomodulation, and cardiovascular regulation, highlighting its potential scientific value.

As a synthetic peptide substance with multi-target regulatory properties, the effects of MT2 primarily rely on its binding affinity to different receptor subtypes. In terms of cardiovascular system regulation, its actions largely depend on the activation of the sympathetic nervous system and direct effects on vascular smooth muscle. These effects are closely associated with the activation of MC4R and MC1R and exhibit clear dose dependency. Simultaneously, in the realm of anti-inflammatory and immunomodulatory functions, MT2 demonstrates potential regulatory effects by targeting specific receptors and modulating inflammatory signaling pathways.

Our Product Form

MT2 Powder

MT2 Injection

MT2 Tablet

MT2 Spray

MT2 COA

MT2 tablets are a non selective melanocortin receptor (MCR) agonist that, in addition to its core tanning effect, can also activate multiple receptor subtypes such as MC1R, MC3R, and MC4R through targeted activation, demonstrating significant potential in anti-inflammatory immune regulation and cardiovascular function regulation. In terms of anti-inflammatory and immune responses, MT-II can exert systemic anti-inflammatory effects by inhibiting the release of pro-inflammatory factors and regulating immune cell activity; In the field of cardiovascular disease, it can have a positive impact on cardiovascular homeostasis through multiple mechanisms such as regulating vascular tone, improving endothelial function, and inhibiting myocardial remodeling.

The anti-inflammatory and immunomodulatory effects of MT2 have become a research hotspot in recent years. Current studies primarily focus on cellular models and animal experiments, with promising future prospects regarding its mechanisms of action, clinical application potential, and long-term safety.

The core molecular basis of this effect lies in the ability of MT2 to specifically bind to melanocortin 5 receptor (MC5R) on the surface of immune cells. By activating downstream signaling pathways, it regulates the functional activity of immune cells, balances inflammatory responses, and contributes to the maintenance of immune homeostasis.

1. Immune regulatory characteristics

 

In addition to its defined anti-inflammatory effects, MT-II also exerts a regulatory influence on the overall homeostasis of the immune system, primarily through precise modulation of immune cell proliferation and differentiation. Under pathological conditions characterized by excessive immune activation (e.g., autoimmune diseases), MT-II can moderately suppress the over-proliferation of immune cells such as T lymphocytes and B lymphocytes by activating the MC5R signaling pathway, thereby reducing the production of abnormal antibodies and inhibiting aberrant immune cell activation. This helps prevent immune dysregulation from attacking the body's own tissues and organs. Leveraging this property, numerous animal studies have explored the potential application of MT-II in autoimmune diseases. For instance, in animal models of rheumatoid arthritis, psoriasis, and systemic lupus erythematosus, MT-II intervention has been shown to significantly alleviate inflammatory damage at lesion sites and improve disease symptoms, suggesting its potential as a therapeutic target for such conditions.

However, it is essential to emphasize that all relevant studies to date are confined to in vitro cellular experiments and animal models. The mechanisms of action, efficacy, dose dependency, and long-term safety of MT-II in humans remain incompletely understood. Moreover, variations in individual immune status may lead to differences in MT-II's effects across individuals. Therefore, further extensive research is required before any clinical application for immune-related diseases can be considered.

2.Immunomodulatory Properties

 

Beyond its anti-inflammatory effects, MT-II also exhibits regulatory influence on the proliferation and differentiation of immune cells. It can moderately suppress the proliferation of overactive immune cells, thereby preventing immune response dysregulation. This suggests its potential research value in interventions for autoimmune diseases, such as rheumatoid arthritis and psoriasis. However, current related studies are largely confined to animal experiments and cellular models. The mechanisms of action, efficacy, and safety of its anti-inflammatory and immunomodulatory effects in humans have not been fully elucidated, necessitating further in-depth exploration.

In addition to its established anti-inflammatory effects, MT-II also exerts a certain regulatory influence on the overall homeostasis of the immune system, primarily through the precise modulation of immune cell proliferation and differentiation. Under pathological conditions characterized by excessive immune activation, such as autoimmune diseases, MT-II can mildly inhibit the overproliferation of immune cells like T lymphocytes and B lymphocytes by activating the MC5R signaling pathway. This reduces the production of abnormal antibodies and suppresses aberrant immune cell activation, thereby preventing immune dysregulation from attacking the body's own tissues and organs.

3.Specific Anti-inflammatory Effects

 

Upon activating MC5R, MT-II can significantly inhibit the release of pro-inflammatory cytokines, including tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β). These cytokines are key mediators of local and systemic inflammatory responses, and reducing their release can effectively alleviate tissue inflammation infiltration and mitigate inflammatory damage. Additionally, MT-II mildly promotes the expression of anti-inflammatory cytokines, such as IL-10, further balancing the body's inflammatory responses.

The regulatory effect of MT2 on the cardiovascular system is an indirect effect of its non selective binding to melanocortin receptors, which mainly relies on the activation of the central sympathetic nervous system, accompanied by direct regulation of vascular smooth muscle cells. The core is closely related to the activation of MC4R and MC1R, and has significant dose-dependent and individual differences.

Effects of Different Dosages of MT-II Tablets on the Cardiovascular System

The regulatory effect of MT-II on the cardiovascular system exhibits clear dose dependency, with significant differences in its manifestations and intensity across various dosage ranges. This can be specifically categorized into three aspects:

(I) Impact on Heart Rate:

Within the low to moderate safe dosage range, activation of central MC4R by MT-II induces sympathetic nervous system excitation, leading to a mild increase in heart rate. This effect results from direct sympathetic modulation of the sinoatrial node and typically manifests as a transient elevation in heart rate, which gradually returns to normal levels within hours as the drug is metabolized. No persistent increase in heart rate is observed under these conditions. However, at high doses, excessive sympathetic excitation may cause a significant acceleration of heart rate or even induce arrhythmias, representing one of the potential risks associated with high-dose MT-II.

(II)Impact on Blood Pressure:

The effect of MT-II on blood pressure also demonstrates dose dependency. At low doses, mild sympathetic excitation leads to slight vasoconstriction and a moderate increase in cardiac output, resulting in a brief and minor elevation in blood pressure. This change typically holds no significant clinical relevance and resolves rapidly. At moderate to high doses, intensified sympathetic excitation causes pronounced vasoconstriction and a notable increase in cardiac output, leading to a significant rise in blood pressure and potential fluctuations. These effects may be more pronounced in individuals with compromised blood pressure regulation.

(III) Regulation of Vascular Tone:

The regulatory effect of MT-II varies across different vascular beds, exhibiting notable tissue specificity:

For cutaneous and visceral vessels, MT-II primarily induces mild vasodilation, enhancing local blood flow and improving tissue perfusion.

For peripheral arteries, it mainly exerts mild vasoconstrictive effects, contributing to the maintenance of peripheral vascular tone and blood pressure stability.

Overall, MT-II helps maintain hemodynamic balance through its differential regulation of various vascular beds. However, the stability and persistence of these effects require further validation through additional animal studies and in vitro research, as their long-term regulatory outcomes remain unclear.

Activation of the sympathetic nervous system and effects on vascular smooth muscle by MT2 

The regulatory effects of MT2 on the cardiovascular system primarily depend on the activation of the sympathetic nervous system and its direct action on vascular smooth muscle, with the activation of MC4R and MC1R being central to these effects, demonstrating significant dose dependency.Therefore, understanding the core regulatory mechanism of MT2 tablets involves two key aspects. On one hand, when MT2 activates MC4R in the central nervous system, it stimulates the sympathetic nervous system, which releases neurotransmitters such as norepinephrine. These neurotransmitters act on the heart and blood vessels, triggering a series of cardiovascular responses. On the other hand, MT-II can directly bind to receptors (such as MC1R) on the surface of vascular smooth muscle cells, regulating their contraction and relaxation, thereby influencing vascular tone

In summary, as a non-selective melanocortin receptor agonist, MT-II demonstrates unique regulatory potential in both anti-inflammatory and immunomodulatory functions as well as cardiovascular system regulation:

By targeting receptors such as MC5R and modulating relevant inflammatory signaling pathways, it achieves bidirectional regulation of the body's inflammatory responses and immune homeostasis, offering novel insights for research into interventions for autoimmune diseases.

In terms of cardiovascular function, through the dual mechanisms of sympathetic nerve regulation and direct action on vascular smooth muscle via activation of MC4R and MC1R, it participates in the regulation of hemodynamic balance, thereby enriching the research perspective on cardiovascular function regulation.However, despite advances in related studies reaching the stages of cellular models and animal experiments, numerous questions remain to be explored and addressed.

Hot Tags: mt2 tablets, China mt2 tablets manufacturers, suppliers, salcatonin injection, intranasal desmopressin acetate, best glp 1 peptide, glucagon like peptide 1, glp1 shot, etelcalcetide structure